Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 1401.00 | 4027.75 | 0.3478 | -0.2252 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 2500.00 | 1861.36 | 3074.00 | 4027.75 | 0.7632 | 0.5691 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4543.00 | 4027.75 | 1.1279 | 1.2283 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2041.00 | 4027.75 | 0.5067 | 0.0863 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 4135.00 | 4027.75 | 1.0266 | 1.0478 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1861.36 | 4560.00 | 4027.75 | 1.1321 | 1.2358 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4526.00 | 4027.75 | 1.1237 | 1.2208 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3959.00 | 4027.75 | 0.9829 | 0.9693 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4625.00 | 4027.75 | 1.1483 | 1.2644 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1788.00 | 4027.75 | 0.4439 | -0.0355 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1861.36 | 4767.00 | 4027.75 | 1.1835 | 1.3267 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4416.00 | 4027.75 | 1.0964 | 1.1723 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 4483.00 | 4027.75 | 1.1130 | 1.2019 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 2015.00 | 4027.75 | 0.5003 | 0.0738 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 4626.00 | 4027.75 | 1.1485 | 1.2648 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1528.00 | 4027.75 | 0.3794 | -0.1624 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4345.00 | 4027.75 | 1.0788 | 1.1409 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3831.00 | 4027.75 | 0.9512 | 0.9121 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1861.36 | 4383.00 | 4027.75 | 1.0882 | 1.1577 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3893.00 | 4027.75 | 0.9665 | 0.9398 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3265.00 | 4027.75 | 0.8106 | 0.6564 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3667.00 | 4027.75 | 0.9104 | 0.8384 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3119.00 | 4027.75 | 0.7744 | 0.5897 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1456.00 | 4027.75 | 0.3615 | -0.1979 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2350.00 | 4027.75 | 0.5835 | 0.2328 |